Protalix BioTherapeutics (AMEX:PLX) is preparing to release its quarterly earnings on Thursday, 2025-08-14. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Protalix BioTherapeutics to report an earnings per share (EPS) of $0.03.
The announcement from Protalix BioTherapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s …